This is part three of a three-part article on policy issues in the Medicare Physician Fee Schedule. The topics covered ...

In the coming years, the mismatch of revenue growth and expense growth for providers of health care will result in ...

When considering health insurance reform options, it’s important to understand how cost sharing interacts with premiums and ...

Late in the evening of June 27, 2025, Senate Republicans released the full text of the latest version of the One Big ...

Efforts to remove, restructure, or completely eliminate public health information from federal websites undermine the ...

The last two years have seen some newly enacted state policies cast aside in short order, followed by a reversion to more ...

Health Affairs' Rob Lott interviews Paula Chatterjee of the University of Pennsylvania about her recent paper that explores ...

Even though serious mental illness is no less chronic a condition than diabetes, Medicare beneficiaries are currently limited ...

The US health care system is already larded with bureaucracy; administrative costs account for nearly a third of total health ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

Health Affairs' Rob Lott interviews Uché Blackstock, CEO and Founder of Advancing Health Equity (AHE), on her experiences ...

The COVID-19 pandemic has led to a dangerous trend: the intentional creation of public health law vacuums, in which no ...